Empowering Omics-based Precision Medicine

with TAIGenomics Solutions

Precision Medicine

Empowering Omics-based

with TAIGenomics Solutions

Multi-omics Analyses Cloud

Multi-omics Analyses Cloud

Explore TAIGenomics

TAIGenomics offers an AI-driven omics data platform that enables healthcare providers and medical researchers to find the next clinical action plan. Our solutions can seamlessly analyze and interpret the experiment or clinical data across different disease areas, including heredity common disease risk, rare disease, and oncology. Partnering with TAIGenomics now to achieve your blueprint about the future of precision medicine.

Efficient omics bioinformatics tool set up & validation

Connecting data and information with AI

Flexible analytics architecture

Link to: Product_QCheck

Accumulate and Validate your omics data quality  with trusted international guidelines.

More information
Link to: Product_GenDiseak

Assist clinical genomics interpretation in rare disease diagnosis.

More information

Perform a patient’s absolute risk of common chronic disease.

More information
Link to: Product_pubmedKB

Discover clinical action plan in real-world knowledge base.

More information

Our Advantages

A scalable analytics platform on the cloud

Automated multi-omics analyses workflows

Ready to use graphical user interface

News

Taiwan’s rapidly cutting-edge medtech transform not only its own healthcare system but also the world’s.

In the year 2020, COVID-19 terrorized the world. Only 7 people in Taiwan died from COVID. Why?

We look at how Taiwan is using artificial intelligence and machine learning in the medical field.

AI can automatically identify tumors from hundreds of MRI images in just 30 seconds! 95% accuracy

AI Labs × Taipei Veterans General Hospital have built the world’s first AI oncology clinical interpretation system

Hospital, lab collaborate on sepsis-detection AI

Top 10 AI Powered Healthcare Companies 2019

News

Taiwan’s rapidly cutting-edge medtech transform not only its own healthcare system but also the world’s.

In the year 2020, COVID-19 terrorized the world. Only 7 people in Taiwan died from COVID. Why?

We look at how Taiwan is using artificial intelligence and machine learning in the medical field.

AI can automatically identify tumors from hundreds of MRI images in just 30 seconds! 95% accuracy

AI Labs × Taipei Veterans General Hospital have built the world’s first AI oncology clinical interpretation system

Hospital, lab collaborate on sepsis-detection AI

Top 10 AI Powered Healthcare Companies 2019

Contact us

Copyright © 2021 TAIGenomics. All Rights Reserved.

Contact us

1. Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases. FDA, Jul. 2016

2. Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics. FDA, Jul. 2016

3. Clinical laboratory standards for next-generation sequencing. ACMG, Sep. 2013.

4. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. ACMG, Mar. 2015.

5. Good laboratory practice for clinical next-generation sequencing informatics pipelines. CDC, Jul. 2015.

6. Guidelines for Validation of Next-Generation Sequencing Based Oncology Panels. AMP/CAP, May. 2017.

7. "Next Generation" Sequencing (NGS) guidelines for somatic genetic variant detection. NYSDOH, Mar. 2015.

8. Guidelines for diagnostic next-generation sequencing. EuroGentest, Oct. 2015.

9. Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice. CDC, Nov. 2012.